on Evotec AG (NASDAQ:EVTCY)
Evotec SE to Announce Q3 2026 Financial Results
Evotec SE, a leading life science company, is set to release its financial results for the first nine months of 2026. The announcement will occur on November 5, 2026. A webcast and conference call will accompany this release, providing a detailed business update. The call will be conducted in English and will start at 2.00 pm CET.
Participants interested in the webcast can register online to access both the audio and the presentation slides. The on-demand version will be available on Evotec's website post-event. For those joining via phone, a pre-registration link is provided to receive specific dial-in details.
Evotec, listed on NASDAQ and the Frankfurt Prime Standard, engages in drug discovery. The company collaborates with top pharmaceutical firms, over 800 biotechs, and various academic institutions.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news